Pharmaceutical case studies illustrating data analytics strategies
New webinar hosted by Xtalks focuses on extracting the most value from data assets.
In this live broadcast, Lisa J. Graham, CEO and Founder of Alkemy Innovation, and Brian Crandall, Analytics Engineer at Seeq, will discuss new data analytics strategies that can enable and redefine biopharmaceutical businesses. The webinar takes place on Monday 12, June 2017 at 11 am EDT (4 pm BST/UK).
Data Rich, Information Poor. Choosing the appropriate data management and visualization components are important. How many times have you wanted to investigate a key issue, or proactively design a new process, only to be stopped in your tracks because you don't have the data you need? Do you often decide that the pain and effort of gathering the data, that you know exists somewhere, isn't worth the time it takes to pull it together?
With the invent of high-speed, high-throughput data acquisition capabilities of recent years, there is a need for high-speed data analytics and visualization. Analytics tools are the most efficient way to get the most value out of the data that is being produced every day. With the proper tools in hand, your data can become one of your greatest assets.
Yet, most processing is still done in user-specific spreadsheets with time-consuming, manual inputs and calculations. Further, when challenges arise, it becomes necessary to couple reams of disparate data sources, often in multiple iterations, to better understand the complex reactor, bioreactor, or purification dynamics.
It is not uncommon for a technical team to need to leverage significant historical data within very tight product development timelines. Therapies need to be quickly transitioned from a proof-of-concept phase to a scale and quality suitable for commercial production, where the company must also demonstrate full knowledge of both the process and the final product quality metrics. With that knowledge, the company can achieve a successful launch, ensure patient safety, and meet regulatory requirements. Data is a tremendous asset that should be captured and made readily available for analysis, which is imperative for
In this webinar, the speakers will focus on specific pharmaceutical case study examples, with a focus on the Seeq software application. Seeq simplifies the extraction of insights and value from data historians and other data sources. Specifically, it allows the scientist or engineer to quickly access and search the data, add context, cleanse, model, find patterns, establish boundaries, monitor assets, and allow collaboration in real time. Our expert speakers will discuss how you can leverage data analytics strategies to achieve
Scientists in pharmaceutical production must be able to thrive in a challenging business environment defined by operational challenges, regulations, market shifts, and competition.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance